A panel of U.S. physicians, statisticians, and other experts has developed treatment guidelines for coronavirus disease 2019 (COVID-19).
Healthcare
African Development Bank Group approves $10 million equity in Razorite Healthcare Fund for Africa
The Board of Directors of the African Development Bank has approved a $10-million equity investment in Razorite Healthcare Africa Fund 1 (RHAF1) to help improve healthcare infrastructure delivery across the continent.
WHO prequalifies first biosimilar medicine to increase life-saving breast cancer treatment
The World Health Organization (WHO), on Wednesday, prequalified its first biosimilar medicine – trastuzumab – in a move that could make this expensive, life-saving treatment more affordable and available to women globally.
Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa
Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa (SSA), which is home to the largest underserved patient population in the world.
Words not enough to improve health outcomes – says World Bank President
World Bank Group President David Malpass’ has said at the 2019 UN High-Level Meeting on Universal Health Coverage (UHC) that accelerating progress toward Universal Health Coverage is critical to alleviating extreme poverty and boosting shared prosperity.
Expanding access to health services with self-care interventions
By 2035, there will be an estimated shortage of nearly 13 million healthcare workers. Around 1 in 5 of the world’s population will be living in settings that are experiencing humanitarian crises.
IARC publication highlights variations in cancer incidence, survival, and mortality that exist between countries
A new Scientific Publication from the International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization (WHO), has examined the global problem of social inequalities in cancer, highlighting the large variations in cancer incidence, survival, and mortality that exist between countries.
